首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Minerva endocrinology

缩写:

ISSN:2724-6507

e-ISSN:2724-6116

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引305
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Giulia Guarino,Renata Bracale,Martina Ingrosso et al. Giulia Guarino et al.
Benedetta DI Marzio,Giulia Gasparini,Andrea Ambrosio et al. Benedetta DI Marzio et al.
Background: Type 2 diabetes mellitus (T2DM) is frequently associated with cognitive decline in the older population. Although optimal glycemic control is known to be essential for disease management, the impact of hypogly...
Sanja Medenica,Roberto Negro,Djordje Popovic et al. Sanja Medenica et al.
Background: Real-time continuous glucose monitoring (RT-CGM) is widely used in patients with type 1 diabetes (T1D) to improve glycemic control by reducing postprandial glucose peaks and hypoglycemic episodes. In addition,...
Meenakshi R Yathindra,Ayush Bhattacharjee,Nikhil Pundir et al. Meenakshi R Yathindra et al.
Survodutide represents an innovative approach to obesity management and metabolic-associated fatty liver disease (MAFLD). These conditions, often closely linked with type 2 diabetes (T2DM) and cardiovascular diseases, demand effective treat...
Suad H Almasoudi,Hayder M Al-Kuraishy,Ali I Al-Gareeb et al. Suad H Almasoudi et al.
Amylin is a peptide hormone co-secreted with insulin from pancreatic β-cells that plays a crucial role in glucose homeostasis. Amylin by inhibiting glucagon secretion, slowing gastric emptying, and reducing food intake improves blood gluco...
Giuseppe Seminara,Marco Leuzzi,Leonardo Meduri et al. Giuseppe Seminara et al.
Background: Male obesity-associated hypogonadism promotes a vicious cycle of sarcopenic obesity and increased cardiometabolic risk. Although tirzepatide is highly effective for weight loss, a subset of "late responders" h...
Sebastián Chapela,Julieta Locatelli,Melannie Toral-Noristz et al. Sebastián Chapela et al.
Menopause brings a series of endocrine changes that significantly increase the risk of developing metabolic syndrome (MetS), a condition characterized by central obesity, dyslipidemia, hypertension, and insulin resistance. In this context, ...
Manar F Atoum,Ala&#x; S Almehsen,Dalia A Alowaisy Manar F Atoum
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the destruction of insulin-producing β-cells in the pancreatic islets, resulting in complete insulin deficiency. The pathogenesis of T1D is multifactorial and includes ...
Davide Sacco,Paolo Brambilla,Luciano Calzari et al. Davide Sacco et al.
Background: Prenatal exposure to dioxin, a known endocrine disruptor, after the Seveso accident of 1976 has been associated with thyroid dysfunction, metabolic syndrome and semen quality reduction. Experimental exposure t...
Sristi Dey,Promit S Roy,Angel Mendonca et al. Sristi Dey et al.
Insulin resistance (IR) is a condition where insulin-targeted tissues (muscle, liver, and adipose tissue) fail to normally respond to insulin action, leading to impaired insulin signaling and hyperglycemia. It is common in individuals with ...